GUANGDONG HYBRIBIO BIOTECH CO.,LTD. Comparaciones Financieras Guangdong Hybribio Biotech Co.,Ltd.
Acciones
300639
CNE100002N51
Equipo médico, suministros y distribución
|
Precio de cierre
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
| 5,240 CNY | -2,24 % |
|
-8,39 % | -43,90 % |
| 28/08 | Guangdong Hybribio Biotech Co.,Ltd. Resultados del semestre finalizado el 30 de junio de 2024 | CI |
| 16/07 | Guangdong Hybribio Biotech obtiene la licencia para instrumentos de laboratorio clínico | MT |
Principales competidores
Añadir a una lista 0 seleccionado | Ventas netas ($) (Y-1) | Margen neto (Y-1) | Margen Operativo (Y-1) | ROE (Y-1) | ROA (Y-1) | Apalancamiento (Dette/EBITDA) (Y-1) | |
|---|---|---|---|---|---|---|---|
| 156 M | +12.72% | +3.86% | +2.88% | - | - | ||
| 4080,61 M | +9.74% | +11.95% | +9.73% | +6.85% | 0.2x | ||
| 554 M | +42.08% | +48.23% | +23.72% | +20.31% | -0.54x | ||
| 1296,43 M | +25.20% | +42.08% | - | - | - | ||
| 1274,71 M | +13.85% | +24.65% | +10.46% | - | 2.07x | ||
| 342 M | -109.65% | -102.19% | +3.05% | +2.43% | 1.08x | ||
| 627 M | +27.40% | +30.73% | +14.92% | +11.05% | -0.43x | ||
| 619 M | -41.23% | -42.88% | -32.98% | -25.59% | 1.69x | ||
| 753 M | -34.96% | -3.39% | -2.71% | -1.93% | 16.25x | ||
| 390 M | +17.64% | +19.86% | +10.86% | +8.08% | - | ||
| 142 M | +35.79% | - | - | - | - | ||
| 147 M | +24.56% | +28.28% | +15.74% | +14.58% | -1.5x | ||
| 246 M | +30.07% | +34.10% | +14.93% | - | - | ||
| 409 M | +10.80% | +11.44% | +4.94% | - | - | ||
| 492 M | -71.33% | -37.83% | -15.56% | -13.27% | 1.3x | ||
| 108 M | -10.36% | -21.32% | -3.73% | - | 7.77x | ||
| Promedio | 727 M | -1,11 % | +3,17 % | +4,02 % | +2,50 % | 2,79x | |
| Media ponderada por Capi. | 1596,35 M | +5,88 % | +12,64 % | +8,28 % | +6,46 % | 1,52x |
- Bolsa de valores
- Acciones
- Acción 300639
- Sector Guangdong Hybribio Biotech Co.,Ltd.
- Comparaciones Financieras
MarketScreener is also available in this country: United States.
Switch edition
Seguir con la edición actual